Changing the approach to type 2 diabetes treatment: A comparison of glucagon‐like peptide‐1 receptor agonists and sulphonylureas across the continuum of care-Reference-Cited by-同舟云学术

Changing the approach to type 2 diabetes treatment: A comparison of glucagon‐like peptide‐1 receptor agonists and sulphonylureas across the continuum of care

Published:2021-02-07 Issue:7 Volume:37 Page:
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metabolism Res

Author:

Orsini Federici Marco¹^ORCID,Gentilella Raffaella¹,Corcos Antonella¹,Torre Enrico²,Genovese Stefano³

Affiliation:

1. Eli Lilly Italia Sesto Fiorentino Italy

2. Asl3 Genovese Head of Endocrinology Diabetology and Metabolic Diseases SSD Genova Italy

3. Centro Cardiologico Monzino IRCCS Head of Diabetology Endocrinology and Metabolic Diseases Unit Milano Italy

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.3434

Reference121 articles.

1. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary

2. Comparative effectiveness of glycemic control in patients with type 2 diabetes treated with GLP-1 receptor agonists: a network meta-analysis of placebo-controlled and active-comparator trials

3. The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems

4. Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments

5. Effects of Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endogenous glucagon‐like peptide (GLP)‐1 as alternative for GLP‐1 receptor agonists: Could this work and how?;Diabetes/Metabolism Research and Reviews;2023-07-24

2. Comparative effect of ginger (an anti-inflammatory medicinal herb) and aspirin (a non-steroidal anti-inflammatory drug) on cytoprotection and body weight changes in male albino Wistar rats;Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale;2023-06-22

3. Effect of dulaglutide injection on weight beyond glycemic control: real-world observational study;Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale;2023-02-16

4. Clinically Both Effects of Weight and Glucose Variability by Oral Semaglutide (Rybelsus) for Younger Female Patient with Type 2 Diabetes (T2D);Journal of Obesity and Diabetes;2022-06-22

5. New practice in semaglutide on type-2 diabetes and obesity: clinical evidence and expectation;Frontiers of Medicine;2022-02